Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi-Reference-Cited by-同舟云学术

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

Published:2017-01 Issue:1 Volume:4 Page:e15-e23
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Visco Carlo,Chiappella Annalisa,Nassi Luca,Patti Caterina,Ferrero Simone,Barbero Daniela,Evangelista Andrea,Spina Michele,Molinari Annalia,Rigacci Luigi,Tani Monica,Rocco Alice Di,Pinotti Graziella,Fabbri Alberto,Zambello Renato,Finotto Silvia,Gotti Manuel,Carella Angelo M,Salvi Flavia,Pileri Stefano A,Ladetto Marco,Ciccone Giovannino,Gaidano Gianluca,Ruggeri Marco,Martelli Maurizio,Vitolo Umberto

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Improvement of overall survival in advanced stage mantle cell lymphoma;Herrmann;J Clin Oncol,2009

2. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network;Dreyling;Leuk Lymphoma,2013

3. Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)

4. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression free survival;Howard;J Clin Oncol,2002

5. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial;Rummel;Lancet,2013

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. More is not always better;Blood;2024-09-05

2. Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era;Annals of Hematology;2024-08-30

3. SOHO State of the Art Updates and Next Questions: Treatment Evolution of Mantle Cell Lymphoma: Navigating the Different Entities and Biological Heterogeneity of Mantle Cell Lymphoma in 2024;Clinical Lymphoma Myeloma and Leukemia;2024-08

4. Modified R-BAC plus BTK inhibitor regimen in newly diagnosed young patients with mantle cell lymphoma: a real-world retrospective study;Annals of Hematology;2024-02-03

5. Recent advances in genomics and therapeutics in mantle cell lymphoma;Cancer Treatment Reviews;2024-01